文献速递主动脉疾病

全身麻醉与局部区域麻醉在胸主动脉腔内修复术中的比较:一项NSQIP分析

General Versus Locoregional Anesthesia in TEVAR: An NSQIP Analysis.
PubMed 文献 · Ann Vasc Surg · 2022-11-26

基于美国外科医师学会国家手术质量改进计划(ACS-NSQIP)2008至2019年数据库,纳入1028例接受胸主动脉腔内修复术(TEVAR)的患者,比较全身麻醉与局部区域麻醉的术后结局。局部区域麻醉组术后住院时间显著短于全身麻醉组,而两组30天死亡率和并发症发生率无显著差异。多变量分析显示全身麻醉是住院时间超过7天的独立预测因素。

要点

  • 局部区域麻醉组术后住院时间中位数4天,短于全身麻醉组的5天,差异有统计学意义。
  • 两组30天死亡率和并发症发生率无显著差异。
  • 全身麻醉是住院时间超过7天的独立预测因素(OR 1.72)。

核心结论

  • 在TEVAR患者中,与全身麻醉相比,局部区域麻醉可显著缩短术后住院时间,且术后死亡率和并发症发生率相似。

研究设计与样本

  • 利用2008至2019年美国外科医师学会国家手术质量改进计划(ACS-NSQIP)数据库,纳入年龄大于18岁、接受TEVAR且现行 procedural terminology 编码为33880、33881、33883、33884或33886的患者,排除同期手术、胸腹主动脉和腹主动脉病变及创伤病例,最终纳入1028例。
  • 采用标准描述性统计、χ2检验、Fisher精确检验和Mann-Whitney U检验比较两组基线特征和术后结局,并运用单变量和多变量logistic回归分析评估住院时间超过7天的独立预测因素。

主要发现

  • 1028例患者中,86.5%接受全身麻醉,13.5%接受局部区域麻醉(如局部麻醉联合监测麻醉护理或区域麻醉)。
  • 局部区域麻醉组与全身麻醉组30天死亡率分别为3.6%和7.9%,差异无统计学意义(P=0.071);30天并发症发生率分别为18.7%和24.8%,差异无统计学意义(P=0.121),包括伤口、肺部、血栓栓塞、肾脏、脓毒症和心脏骤停并发症。
  • 全身麻醉组术后住院时间中位数为5天(四分位距3-10天),局部区域麻醉组为4天(四分位距2-7天),差异有统计学意义(P=0.002);全身麻醉组住院时间超过7天的比例为34.3%,局部区域麻醉组为21.6%,差异有统计学意义(P=0.003)。
  • 多变量logistic回归分析显示,全身麻醉是住院时间超过7天的独立预测因素(OR 1.72,95%CI 1.05-2.81,P=0.031)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Thoracic Endovascular Aortic Repair (TEVAR) is a minimally invasive surgery for repairing thoracic aneurysms and dissections. This study aims to compare postoperative outcomes of TEVAR performed under general versus locoregional anesthesia. METHODS: Utilizing the 2008-2019 American College of Surgeons National Surgical Quality Improvement Program (ACS-NSQIP) database, patients older than the age of 18 years who received TEVAR, were identified using the following current procedural terminology codes: 33,880, 33,881, 33,883, 33,884, or 33,886. Patients who underwent concomitant procedures, those with both thoracoabdominal and abdominal aortic pathologies, and trauma cases were excluded. Standard descriptive statistics, in addition to χ2, Fisher's exact test, and Mann-Whitney U-tests were used to compare patient baseline characteristics and postoperative outcomes between general and locoregional anesthesia groups as appropriate. Univariable and multivariable logistic regression analyses were performed to assess independent predictors of hospital length of stay (LOS) greater than 7 days. RESULTS: Of the 1,028 patients included in the study, 86.5% received general anesthesia, and 13.5% received locoregional anesthesia, such as local anesthesia with monitored anesthesia care or regional anesthesia. No significant differences were found between patients receiving locoregional versus general anesthesia in mortality (3.6% vs. 7.9%, respectively, P = 0.071) and morbidity (18.7% and 24.8%, respectively, P = 0.121) within 30 days post-TEVAR, including any wound, pulmonary, thromboembolic, renal, septic, and cardiac arrest complications. Patients who received general anesthesia had significantly higher median LOS compared to those who received locoregional anesthesia [5 days (interquartile range (IQR): 3-10) versus 4 days (IQR: 2-7), P = 0.002], with 34.3% of the general anesthesia group having an LOS greater than 7 days compared to 21.6% of locoregional anesthesia group, P = 0.003. On multivariable logistic regression analysis, general anesthesia was found to be an independent predictor of prolonged LOS greater than 7 days (odds ratio (OR): 1.72, 95% confidence interval (CI): 1.05-2.81, P = 0.031). CONCLUSIONS: Locoregional anesthesia results in significantly lower postoperative hospital LOS with similar postoperative mortality and morbidity compared to general anesthesia in patients undergoing TEVAR.

来源:Ann Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Panossian VS, Berro MM, Ismail AM, et al. General Versus Locoregional Anesthesia in TEVAR: An NSQIP Analysis. Ann Vasc Surg. 2022. PMID: 36574571. doi:10.1016/j.avsg.2022.10.008

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。